MEDTRONIC SEEKING "INSTENT" GRATIFICATION OF ITS EXPANDING STENT DESIRES WITH $200 MIL. MERGER; DEAL WOULD GIVE COMPANY "BROADEST STENT LINE"
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's planned acquisition of InStent will provide the firm with a line of nitinol stents that includes self-expanding coronary, vascular, gastroenterological and urology devices, as well as a balloon-expandable coronary product. The addition of the InStent devices would give Medtronic "the broadest line of stents in the industry," Medtronic says.